Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v2-FR
Language English French
Date Updated 2019-09-06 2019-07-26
Drug Identification Number 02463733 02463733
Brand name BUSULFAN FOR INJECTION BUSULFAN FOR INJECTION
Common or Proper name BUSULFAN FOR INJECTION BUSULFAN FOR INJECTION
Company Name STERIMAX INC STERIMAX INC
Ingredients BUSULFAN BUSULFAN
Strength(s) 6MG 6MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 8 VIALS 8 VIALS
ATC code L01AB L01AB
ATC description ALKYLATINGAGENTS ALKYLATINGAGENTS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2019-07-26 2019-07-26
Estimated end date 2019-08-30 2019-08-30
Actual end date 2019-09-05
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments 6 weeks of stock is available at McKesson.
Health Canada comments